These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 28293019)
1. Novel adipokines: methodological utility in human obesity research. Eichelmann F; Rudovich N; Pfeiffer AF; Schulze MB; Giuseppe RD; Boeing H; Aleksandrova K Int J Obes (Lond); 2017 Jun; 41(6):976-981. PubMed ID: 28293019 [TBL] [Abstract][Full Text] [Related]
2. The relationship between circulating visfatin/nicotinamide phosphoribosyltransferase, obesity, inflammation and lipids profile in elderly population, determined by structural equation modeling. Owczarek AJ; Olszanecka-Glinianowicz M; Kocełak P; Bożentowicz-Wikarek M; Brzozowska A; Mossakowska M; Puzianowska-Kuźnicka M; Grodzicki T; Więcek A; Chudek J Scand J Clin Lab Invest; 2016 Dec; 76(8):632-640. PubMed ID: 27712122 [TBL] [Abstract][Full Text] [Related]
3. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids. Chang YC; Chang TJ; Lee WJ; Chuang LM Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775 [TBL] [Abstract][Full Text] [Related]
4. Visfatin/Nampt: an adipokine with cardiovascular impact. Romacho T; Sánchez-Ferrer CF; Peiró C Mediators Inflamm; 2013; 2013():946427. PubMed ID: 23843684 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of visfatin and omentin-1 in patients with psoriasis and their relation to disease severity. Ismail SA; Mohamed SA Br J Dermatol; 2012 Aug; 167(2):436-9. PubMed ID: 22486212 [TBL] [Abstract][Full Text] [Related]
6. Adipokine Visfatin's Role in Pathogenesis of Diabesity and Related Metabolic Derangements. Kumari B; Yadav UCS Curr Mol Med; 2018; 18(2):116-125. PubMed ID: 29974830 [TBL] [Abstract][Full Text] [Related]
7. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models. Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839 [TBL] [Abstract][Full Text] [Related]
9. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges. Dalamaga M Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056 [TBL] [Abstract][Full Text] [Related]
10. Adipokines: a novel link between adiposity and carotid plaque vulnerability. Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969 [TBL] [Abstract][Full Text] [Related]
11. Methodological utility of chemerin as a novel biomarker of immunity and metabolism. Eichelmann F; Weikert C; di Giuseppe R; Biemann R; Isermann B; Schulze MB; Boeing H; Aleksandrova K Endocr Connect; 2017 Jul; 6(5):340-347. PubMed ID: 28592510 [TBL] [Abstract][Full Text] [Related]
12. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations. Ciresi A; Amato MC; Pizzolanti G; Giordano C Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992 [TBL] [Abstract][Full Text] [Related]
13. Snoring, inflammatory markers, adipokines and metabolic syndrome in apparently healthy Chinese. Sun L; Pan A; Yu Z; Li H; Shi A; Yu D; Zhang G; Zong G; Liu Y; Lin X PLoS One; 2011; 6(11):e27515. PubMed ID: 22110665 [TBL] [Abstract][Full Text] [Related]
14. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression. Moschen AR; Molnar C; Wolf AM; Weiss H; Graziadei I; Kaser S; Ebenbichler CF; Stadlmann S; Moser PL; Tilg H J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840 [TBL] [Abstract][Full Text] [Related]